(Autologous Protein Solution)

Nstride Injections

Nstride, Autologous Protein Solution (APS), stands as a revolutionary advancement in orthopedic medicine, particularly in the treatment of osteoarthritis (OA). This innovative solution offers a non-invasive approach to managing knee arthritis, utilizing the patient’s own blood to create a potent therapeutic solution. Through a process of separating white blood cells and platelets from the patient’s blood and concentrating them within a small volume of plasma using the APS kit, Nstride harnesses the body’s natural healing mechanisms to combat OA.

Compared to traditional methods of treating OA, Nstride boasts several significant benefits. Firstly, it is a minimally invasive procedure involving just a single injection, eliminating the need for complex surgeries or prolonged recovery periods. Moreover, studies have shown that Nstride injections can lead to a remarkable reduction in inflammation and pain associated with knee arthritis, with some patients experiencing up to a 70% reduction in symptoms for up to two years following treatment.

In addition to pain relief, Nstride also demonstrates the ability to improve mobility in the treated knee, allowing patients to regain functionality and engage in daily activities more comfortably. Furthermore, Nstride acts as a protective shield for cartilage, helping to prevent further degeneration and deterioration of joint health. 

Nstride Injections

By promoting cartilage cell proliferation, Nstride supports the regeneration and repair of damaged tissue, thereby contributing to long-term joint health and function.

An important advantage of Nstride is its autologous nature, meaning it is derived from the patient’s own blood, eliminating the risk of adverse reactions or complications often associated with synthetic treatments or donor-derived products. This personalized approach not only ensures safety but also enhances the efficacy of the treatment by utilizing the body’s own healing factors.

Overall, Nstride represents a significant advancement in the management of knee osteoarthritis, offering patients a safe, effective, and minimally invasive treatment option that addresses the underlying causes of the condition. With its ability to reduce pain, improve mobility, and protect cartilage, Nstride holds great promise in enhancing the quality of life for individuals suffering from knee arthritis, providing a pathway to long-term joint health and functionality.

Conditions treated with Nstride Injections

Mild to moderate Osteoarthritis knee

Mild to moderate Osteoarthritis hip

Mild to moderate



Mild to moderate Osteoarthritis ankle

Benefits of Nstride injections

Nstride Autologous Protein Solution (APS) is a cutting-edge regenerative therapy that harnesses the body’s natural healing mechanisms to promote tissue repair and regeneration. By isolating and concentrating proteins and growth factors from the patient’s own blood, nStride APS offers a personalized treatment approach with numerous benefits. When injected into damaged tissues, nStride APS stimulates cell proliferation, collagen synthesis, and tissue remodeling, facilitating accelerated healing and reduced pain. This innovative therapy has shown promising results in treating various musculoskeletal conditions, including osteoarthritis, tendon injuries, and ligament damage. Moreover, nStride APS is minimally invasive, well-tolerated, and associated with minimal side effects, making it a safe and effective option for patients seeking alternatives to surgery or traditional treatments. With its ability to enhance healing and improve outcomes, nStride APS stands as a valuable tool in regenerative medicine, offering hope for patients looking to restore function and mobility.

Start your journey with us

Arrange a FREE 15 minute consultation with one of our leading regenerative orthopaedic pain &
care management specialists